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Non-infected central venous
catheters in hemodialysis patients
are not associated with
inflammation
To the Editor: A recent study, conducted by Goldstein et al.,
showed that the serum C-reactive protein (CRP) level of
patients who underwent hemodialysis (HD) with non-
infected central venous catheters (CVCs) was higher than
that of those who underwent HD via native arteriovenous
ﬁstulas (AVFs). In these patients, betadine solution was used
for exit-site care.1 Our aim was to evaluate the changes in the
serum CRP levels of HD patients who underwent dialysis via
native AVF (AVF-1), then via temporary tunneled CVC for
AVF dysfunction, and again via AVF (AVF-2). Eighteen
tunneled jugular CVCs in 18 HD patients were included.
Heparin lock and alcoholic-chlorhexidine solution was used
for exit-site disinfection. The mean CRP values during the
three periods were not different (Figure 1). A cross-sectional
study in 225 HD patients in December 2008 showed that
the median serum CRP levels of patients using AVF (89%)
and CVC (11%) were 7 (IQR 3–20) and 10 (3–21)mg/l,
respectively (NS). We have previously shown that the
incidence of catheter-related bacteremia decreased from
1.1 to 0.2/1000 catheter day during 1994–1997 and
2004–2007 when betadine was substituted with alcohol-
chlorhexidine solution.2 As this solution was more efﬁcient
than betadine in our hands, we hypothesized that the
difference in the ﬁndings reported in the two studies may
be attributed to the differences in the solution used. However,
to conﬁrm this hypothesis, a controlled study should be
conducted in order to compare these two protocols.
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The Authors Reply: We thank Dr Jean and colleagues1 for
their interest in our work.2 They question our ﬁndings of
increased C-reactive protein (CRP) using a non-infected
hemodialysis catheter. The ﬁndings of their study contradict
ours, and all previous studies, which reported an increase in
the inﬂammation associated with catheter use compared with
arteriovenous ﬁstulas.3–5 One study4 assessed 128 prevalent
chronic hemodialysis patients (2405 CRP measurements),
ﬁnding catheter presence was independently associated with
CRP level, and catheter placement or removal was associated
with an increase or improvement in CRP level, respectively.
Our study was the ﬁrst to evaluate non-infected catheters as a
sole mechanism for inﬂammation, adjusted for potential
confounding variables. The authors hypothesize the reason
that they did not observe increased CRP in catheter patients
was because of different antiseptic use for exit site care. They
propose a controlled study to directly address the potential for
inﬂammation induction between two protocols. The informa-
tion accumulated in the literature makes such a study
unnecessary and potentially unethical. Even though the
authors’ hypothesis is correct, we are concerned their letter
implies catheter use is acceptable based on their small study.
Our group, and others, believes catheters should be avoided in
dialysis patients. In addition to inﬂammation, the increase
in morbidity and mortality associated with catheters is well
established.2 A recent paper ‘Ethical and Legal Obligation to
Avoid Long-Term Tunneled Catheter Access’ reminds us the
ﬁrst duty of a physician is to do no harm.6 In our opinion the
continued catheter use is harmful.
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Figure 1 |CRP evolution. Changes in serum C-reactive protein
(CRP) levels of patients undergoing dialysis first via arteriovenous
fistula (AVF-1), then via central venous catheter (CVC), and again
via arteriovenous fistula (AVF-2). Median (interquartile range)
values are shown.
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